Read + Share
Rodriguez-Abreu D, Cobo M, Garcia-Roman S, Viteri-Ramirez S, et al. The EPICAL trial, a phase Ib study combining first line afatinib with anti-EGF
vaccination in EGFR-mutant metastatic NSCLC. Lung Cancer 2022;164:8-13.
PMID: 34971901
|
 |
|
Rodriguez-Abreu D, Cobo M, Garcia-Roman S, Viteri-Ramirez S, et al. The EPICAL trial, a phase Ib study combining first line afatinib with anti-EGF
vaccination in EGFR-mutant metastatic NSCLC. Lung Cancer 2022;164:8-13.
PMID: 34971901
|
|
|
|